Potent inhibitors of human immunodeficiency virus type 1 integrase: Identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 1041-1055

  Neamati, Nouri ^a   Hong, Huixiao ^a   Sunder, Sanjay ^a   Milne, George W A ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DRUG CARRIER; INTEGRASE; ROLITETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CYTOTOXICITY; DNA BINDING; DRUG POTENCY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SOLUBILITY; VIRUS REPLICATION;

EID: 0031469396     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.1041     Document Type: Article

References (39)

1. Pommier, Y., A. Pilon, K. Bajaj, A. Mazumder, and N. Neamati. HIV-1 integrase as a target for antiviral drugs. Antiviral Chem. Chemother. 8: 483-503 (1997).
2. Neamati, N., S. Sunder, and Y. Pommier. Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today 2: 487-498 (1997).
3. Robinson, W. E., Jr., M. Cordeiro, S. Abdel-Malek, Q. Jia, S. A. Chow, M. G. Reinecke, and W. M. Mitchell. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol. Pharmacol. 50:846-855 (1996).
4. Robinson, W. E., Jr., M. G. Reinecke, S. Abdel-Malek, Q. Jia, and S. A. Chow. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93:6326-3631 (1996).
5. Scarpati, M. L., and G. Oriente. Chicoric acid (dicaffeyltartic acid): its isolation from chicory (Chicorium intybus) and synthesis. Tetrahedron 4:43-48 (1958).
6. Cheminat, A., R. Zawatzky, H. Becker, and R. Brouillard. Caffeoyl conjugates from echinacea species: structures and biological activity. Phytochemistry 27:2782-2794 (1988).
7. Mahmood, N., P. S. Moore, N. De Tommasi, F. De Simone, S. Colman, A. J. Hay, and C. Pizza. Inhibition of HIV infection by caffeoylquinic acid derivatives. Antiviral. Chem. Chemother. 4:235-240 (1993).
8. Parker, W. B., M. Nishizawa, M. H. Fisher, N. Ye, K.-H. Lee, and Y.-C. Cheng. Characterization of a novel inhibitor of human DNA polymerases: 3,4,5-tri-O-galloylquinic acid. Biochem. Pharmacol. 38:3759-3765 (1989).
9. Rice-Evans, C. Plant polyphenols: free radical scavenger or chain-breaking antioxidants? Biochem. Soc. Symp. 61:103-116 (1995).
10. Neamati, N., H. Hong, A. Mazumder, S. Wang, S. Sunder, M. C. Nicklaus, G. W. A. Milne, B. Proksa, and Y. Pommier. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J. Med. Chem. 40:942-951 (1997).
11. Nicklaus, M. C., N. Neamati, H. Hong, A. Mazumder, S. Sunder, J. Chen, G. W. A. Milne, and Y. Pommier. HIV-1 integrase pharmacophore: discovery of inhibitors through 3D database searching. J. Med. Chem. 40:920-929 (1997).
12. Hong, H., N. Neamati, S. Wang, M. C. Nicklaus, A. Mazumder, Y. Pommier, H. Zhao, J. T. R. Burke, and G. W. A. Milne. Discovery of HIV-1 integrase inhibitors by pharmacophore searching. J. Med. Chem. 40:930-936 (1997).
13. Mazumder, A., N. Neamati, A. A. Pilon, S. Sunder, and Y. Pommier. Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site: implications for the role of lysine 136 in DNA binding. J. Biol. Chem. 271:27330-27338 (1996).
14. Mazumder, A., N. Neamati, S. Sunder, J. Owen, and Y. Pommier. Retroviral integrase: a novel target in antiviral development; basic in vitro assays with the purified enzyme, in Methods in Cellular and Molecular Biology: Antiviral Evaluation (D. Kinchington and R. Schinazi, eds.). The Humana Press, Totowa, NJ, in press.
15. Mazumder, A., N. Neamati, J. P. Sommadossi, G. Gosselin, R. F. Schinazi, J. L. Imbach, and Y. Pommier. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. Mol. Pharmacol. 49:621-8 (1996).
16. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (Washington D. C.) 255:723-726 (1992).
17. Pommier, Y., G. Kohlhagen, K. W. Kohn, F. Leteurtre, M. C. Wani, and M. E. Wall. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase 1-DNA cleavage sites. Proc. Natl. Acad. Sci. USA 92:8861-8865 (1995).
18. Milne, G. W. A., M. C. Nicklaus, J. S. Driscoll, S. Wang, and D. W. Zaharevitz. The NCI drug information system 3D database. J. Chem. Inf. Comput. Sci. 34:1219-1224 (1994).
19. Milne, G. W. A., and J. A. Miller. The NCI drug information system. J. Chem. Inf. Comput. Sci. 26:154-197 (1986).
20. Milne, G. W. A., S. Wang, and M. C. Nicklaus. Molecular modeling in the discovery of drug leads. J. Chem. Inf. Comput. Sci. 36:726-730 (1996).
21. Wang, S., D. W. Zaharevitz, R. Sharma, V. E. Marquez, N. E. Lewin, L. Du, P. M. Blumberg, and G. W. A. Milne. The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database search: molecular modeling studies. J. Med. Chem. 37:4479-4489 (1994).
22. Wang, S., G. W. A. Milne, X. Yan, I. Posey, M. C. Nicklaus, L. Graham, and W. G. Rice. Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching. J. Med. Chem. 39:2047-2054 (1996).
23. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. CHARMm: a program for macromolecular energy minimization and dynamics calculations. J. Comput. Chem. 4:187-217 (1983).
24. Nicklaus, M. C., S. Wang, J. S. Driscoll, and G. W. A. Milne. Conformational changes of small molecules binding to proteins. Bioorg. Med. Chem. 3:411-428 (1995).
25. Fesen, M. R., Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608 (1994).
26. Zhao, H., N. Neamati, A. Mazumder, S. Sunder, Y. Pommier, and T. R. Burke, Jr. Arylamide inhibitors of HIV-1 integrase. J. Med. Chem. 40: 1186-1194 (1997).
27. Fesen, M. R., K. W. Kohn, F. Leteurtre, and Y. Pommier. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. USA 90:2399-403 (1993).
28. Natarajan, K., S. Singh, T. R. Burke, D. Grunberger, and B. B. Aggarwal. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:9090-9095 (1996).
29. Gnabre, J. N., J. N. Brady, D. J. Clanton, Y. Ito, J. Dittmer, R. B. Bates, and R. C. C. Huang. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. USA 92:11239-11243 (1995).
30. Baxter, N. J., T. H. Lilley, E. Haslam, and M. P. Williamson. Multiple interaction between polyphenols and a salivary proline-rich protein repeat results in complexation and precipitation. Bichemistry 36:5566-5577 (1997).
31. Rice, P., R. Craigie, and D. R. Davies. Retroviral integrases and their cousins. Curr. Opin. Struct. Biol. 6:76-83 (1996).
32. Katz, R. A., and A. M. Skalka. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173 (1994).
33. Engelman, A., K. Mizuuchi, and R. Craigie. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67:1211-1221 (1991).
34. Mazumder, A., S. Wang, N. Neamati, M. Nicklaus, S. Sunder, J. Chen, G. W. Milne, W. G. Rice, T. R. Burke, Jr., and Y. Pommier. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J. Med. Chem. 39:2472-2481 (1996).
35. Vink, C., E. Yeheskiely, G. A. van der Marel, J. H. van Boom, and R. H. Plasterk. Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res. 19:6691-6698 (1991).
36. Jenkins, T. M., A. B. Hickman, F. Dyda, R. Ghirlando, D. R. Davies, and R. Craigie. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc. Natl. Acad. Sci. USA 92:6057-6061 (1995).
37. Bujacz, G., M. Jaskolski, J. Alexandratos, A. Wlodawer, G. Merkel, R. A. Katz, and A. M. Skalka. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure 4:89-96 (1996).
38. Gulbis, J., and J. Everett, G. W. Metal binding characteristics of tetracycline derivatives in DMSO solution. Tetrahedron 32:913-917 (1976).
39. Williamson, D. E., and J. Everett, G. W. A proton nuclear magnetic resonance study of the site of metal binding in tetracycline. J. Am. Chem. Soc. 97:2397-2405 (1975).